Login / Signup

Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.

Loey Lung-Yi MakMichael KoElvis ToDanny Ka-Ho WongJustin Hei-Chun MaTeresa Lok-Yee HuiWai-Kay SetoJames FungChing-Lung LaiMan Fung Yuen
Published in: Journal of gastroenterology and hepatology (2019)
Baseline and 3-year serum M2BPGi may be useful to identify high risk patients on antiviral treatment for subsequent HCC development.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • binding protein
  • peritoneal dialysis
  • prognostic factors
  • smoking cessation
  • patient reported